Interstitial Lung Disease due to Tepotinib after Durvalumab in a Patient with Lung Adenocarcinoma Harbouring MET Exon 14 Skipping Mutation: A Case Report - Ryota Tatsuhige; Keiki Yokoo; Taku Hatakeyama; Takayuki Nagao; Satoshi Ota; Gen Yamada; Hirofumi Chiba (Case Reports in Oncology)